MariMed Inc (MRMD)
0.1495
0.00 (0.00%)
USD |
OTCM |
Nov 22, 16:00
MariMed Revenue (Quarterly): 40.59M for Sept. 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 40.59M |
| June 30, 2024 | 40.44M |
| March 31, 2024 | 37.93M |
| December 31, 2023 | 38.90M |
| September 30, 2023 | 38.80M |
| June 30, 2023 | 36.52M |
| March 31, 2023 | 34.38M |
| December 31, 2022 | 35.83M |
| September 30, 2022 | 33.91M |
| June 30, 2022 | 32.99M |
| March 31, 2022 | 31.28M |
| December 31, 2021 | 31.04M |
| September 30, 2021 | 33.21M |
| June 30, 2021 | 32.57M |
| March 31, 2021 | 24.64M |
| December 31, 2020 | 20.36M |
| September 30, 2020 | 13.46M |
| June 30, 2020 | 9.610M |
| March 31, 2020 | 7.466M |
| December 31, 2019 | 5.192M |
| September 30, 2019 | 11.22M |
| June 30, 2019 | 25.67M |
| March 31, 2019 | 3.516M |
| December 31, 2018 | 3.440M |
| September 30, 2018 | 3.392M |
| Date | Value |
|---|---|
| June 30, 2018 | 2.937M |
| March 31, 2018 | 2.083M |
| December 31, 2017 | 1.580M |
| September 30, 2017 | 1.716M |
| June 30, 2017 | 1.621M |
| March 31, 2017 | 1.151M |
| December 31, 2016 | 1.429M |
| September 30, 2016 | 0.8735M |
| June 30, 2016 | 0.6474M |
| March 31, 2016 | 0.6145M |
| December 31, 2015 | 0.7266M |
| September 30, 2015 | 0.3928M |
| June 30, 2015 | 0.0545M |
| March 31, 2015 | 0.0962M |
| December 31, 2014 | 0.0877M |
| September 30, 2014 | 0.0002M |
| June 30, 2014 | 0.0002M |
| March 31, 2014 | 0.0002M |
| December 31, 2013 | 0.0002M |
| September 30, 2013 | 0.0004M |
| June 30, 2013 | 0.0001M |
| March 31, 2013 | 0.0002M |
| December 31, 2012 | 0.0001M |
| September 30, 2012 | 0.0002M |
| June 30, 2012 | 0.0002M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
5.192M
Minimum
Dec 2019
40.59M
Maximum
Sep 2024
28.96M
Average
33.10M
Median
Revenue (Quarterly) Benchmarks
| cbdMD Inc | 5.174M |
| Flora Growth Corp | 12.46M |
| NovaBay Pharmaceuticals Inc | 2.441M |
| Palatin Technologies Inc | -- |
| iBio Inc | -- |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.011M |
| Total Expenses (Quarterly) | 39.00M |
| EPS Diluted (Quarterly) | -0.0027 |
| Enterprise Value | 120.97M |
| Gross Profit Margin (Quarterly) | 41.33% |
| Profit Margin (Quarterly) | -2.49% |
| Earnings Yield | -27.07% |
| Operating Earnings Yield | 13.62% |
| Normalized Earnings Yield | -11.06 |